Board of Glaxosmithkline Pharmaceuticals approves change in MD
At meeting held on 17 October 2022
The Board of Glaxosmithkline Pharmaceuticals at its meeting held on 17 October 2022 has approved the appointment of Bhushan Akshikar (DIN: 09112346) as a Managing Director. He succeeds Sridhar Venkatesh who is moving to a new senior role within GSK Group effective 1 December 2022.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content